DNAM-1: An amplifier of immune responses as a therapeutic target in various disorders

Current Opinion in Investigational Drugs

Volumn 9, Issue 5, 2008, Pages 491-496

  Elishmereni, M ^a   Bachelet, I ^a   Levi Schaffer, F ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Adhesion molecule; Allergic inflammation; Cancer; Co stimulatory molecule; Glycoprotein

Indexed keywords

CELL ADHESION MOLECULE; DNAX ACCESSORY MOLECULE 1; GLYCOPROTEIN; LIGAND; NECTIN 2; VIRUS RECEPTOR;

ALLERGY; AUTOIMMUNE DISEASE; CELL ACTIVATION; CYTOLYSIS; DRUG EFFECT; DRUG MECHANISM; DRUG STRUCTURE; GENETICS; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; NATURAL KILLER T CELL; NEOPLASM; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOLOGY; POLIOMYELITIS VIRUS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; T LYMPHOCYTE; TARGET CELL;

ANIMALS; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; AUTOIMMUNE DISEASES; CELL ADHESION MOLECULES; HUMANS; HYPERSENSITIVITY; LIGANDS; NEOPLASMS; RECEPTORS, VIRUS; SIGNAL TRANSDUCTION;

EID: 43549105875     PISSN: 14724472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (55)

1. Aricescu AR, Jones EY: Immunoglobulin superfamily cell adhesion molecules: Zippers and signals. Curr Opin Cell Biol (2007) 19(5):543-550.
2. Peggs KS, Allison JP: Co-stimulatory pathways in lymphocyte regulation: The immunoglobulin superfamily. Br J Haematol (2005) 130(6):809-824.
3. Bachelet I, Levi-Schaffer F: Mast cells as effector cells: A co-stimulating question. Trends Immunol (2007) 28(8):360-365.
4. Dong C, Nurieva RI, Prasad DV: Immune regulation by novel costimulatory molecules. Immunol Res (2003) 28(1):39-48.
5. Hodge JW, Greiner JW, Tsang KY, Sabzevari H, Kudo-Saito C, Grosenbach DW, Gulley JL, Arlen PM, Marshall JL, Panicali D, Schlom J: Costimulatory molecules as adjuvants for immunotherapy. Front Biosci (2006) 11(1):788-803.
6. Kroczek R, Hamelmann E: T-cell costimulatory molecules: Optimal targets for the treatment of allergic airway disease with monoclonal antibodies. J Allergy Clin Immunol (2005) 116(4):906-909.
7. Zöller M: Costimulatory molecules and their ligands as therapeutic targets in autoimmune disease. Eur J Dermatol (2001) 11(4):335-342.
8. Bachelet I, Munitz A, Mankutad D, Levi-Schaffer F: Mast cell costimulation by CD226/CD112 (DNAM-1/nectin-2): A novel interface in the allergic process. J Biol Chem (2006) 281(37):27190-27196. • This is the first paper that implicates DNAM-1 in allergic inflammation. The researchers provided evidence that this molecule synergizes with the FcεRI receptor to augment the activation of mast cells.
9. Carlsten M, Björkström NK, Norell H, Bryceson Y, van Hall T, Baumann BC, Hanson M, Schedvins K, Kiessling R, Ljunggren HG, Malmberg KJ: DNAX accessory molecule-1 mediated recognition of freshly isolated ovarian carcinoma by resting natural killer cells. Cancer Res (2007) 67(3):1317-1325.
10. Chen L, Xie X, Zhang X, Jia W, Jian J, Song C, Jin B: The expression, regulation and adhesion function of a novel CD molecule, CD226, on human endothelial cells. Life Sci (2003) 73(18):2373-2382.
11. Jian JL, Zhu CS, Xu ZW, Ouyang WM, Ma DC, Zhang Y, Chen LJ, Yang AG, Jin BQ: Identification and characterization of the CD226 gene promoter. J Biol Chem (2006) 281(39):28731-28736.
12. Kojima H, Kanada H, Shimizu S, Kasama E, Shibuya K, Nakauchi H, Nagasawa T, Shibuya A: CD226 mediates platelet and megakaryocytic cell adhesion to vascular endothelial cells. J Biol Chem (2003) 278(38):36748- 36753. • An elegant study that demonstrated that DNAM-1 is expressed on endothelial cells, and can induce their activation and aggregation.
13. Ma D, Sun Y, Lin D, Wang H, Dai B, Zhang X, Ouyang W, Jian J, Jia W, Xu X, Jin B: CD226 is expressed on the megakaryocytic lineage from hematopoietic stem cells/progenitor cells and involved in its polyploidization. Eur J Haematol (2005) 74(3):228-240.
14. Ralston KJ, Hird SL, Zhang X, Scott JL, Jin B, Thorne RF, Berndt MC, Boyd AW, Burns GF: The LFA-1-associated molecule PTA-1 (CD226) on T cells forms a dynamic molecular complex with protein 4.1G and human discs large. J Biol Chem (2004) 279(32):33816-33828.
15. Shibuya A, Campbell D, Hannum C, Yssel H, Franz-Bacon K, McClanahan T, Kitamura T, Nicholl J, Sutherland GR, Lanier LL, Phillips JH: DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes. Immunity (1996) 4(6):573-581. •• This study was the first to describe the expression and structure of DNAM-1, and demonstrated its functionality in mediating immune cytotoxicity.
16. Shibuya A, Lanier LL, Phillips JH: Protein kinase C is involved in the regulation of both signaling and adhesion mediated by DNAX accessory molecule-1 receptor. J Immunol (1998) 161(4):1671-1676. • In this paper, the researchers demonstrated the significance of PKC in phosphorylating the DNAM-1 molecule and inducing its activity for the first time.
17. Shibuya K, Shirakawa J, Kameyama T, Honda S, Tahara-Hanaoka S, Miyamoto A, Onodera M, Sumida T, Nakauchi H, Miyoshi H, Shibuya A: CD226 (DNAM-1) is involved in lymphocyte function-associated antigen 1 costimulatory signal for naive T cell differentiation and proliferation. J Exp Med (2003) 198(12):1829-1839.
18. Shirakawa J, Shibuya K, Shibuya A: Requirement of the serine at residue 329 for lipid raft recruitment of DNAM-1 (CD226). Int Immunol (2005) 17(3):217-223.
19. 2+ elevation. Zhonghua Xue Ye Xue Za Zhi (1998) 19(3):133-137.
20. Sun K, Jin BQ, Feng Q, Zhu Y, Yang K, Liu XS, Dong BQ: Identification of CD226 ligand on colo205 cell surface. World J Gastroenterol (2002) 8(1):108-113.
21. Tahara-Hanaoka S, Miyamoto A, Hara A, Honda S, Shibuya K, Shibuya A: Identification and characterization of murine DNAM-1 (CD226) and its poliovirus receptor family ligands. Biochem Biophys Res Commun (2005) 329(3):996-1000.
22. Ye X, Zhang Z, Jiang Y, Han X, Wang Y, Zhang M, Liu J, Geng W, Dai D, Shi W, Shang H: Expression of human CD226 on T cells and natural killer cells and of soluble CD226 in plasma of HIV-1-infected Chinese patients. Viral Immunol (2006) 19(3):576-581.
23. Dardalhon V, Schubart AS, Reddy J, Meyers JH, Monney L, Sabatos CA, Ahuja R, Nguyen K, Freeman GJ, Greenfield EA, Sobel RA et al: CD226 is specifically expressed on the surface of Th1 cells and regulates their expansion and effector functions. J Immunol (2005) 175(3):1558-1565.
24. Sen Y, Yongyi B, Yuling H, Luokun X, Li H, Jie X, Tao D, Gang Z, Junyan L, Chunsong H, Zhang X et al: V α 24-invariant NKT cells from patients with allergic asthma express CCR9 at high frequency and induce Th2 bias of CD3+ T cells upon CD226 engagement. J Immunol (2005) 175(8):4914-4926.
25. Fuchs A, Cella M, Giurisato E, Shaw AS, Colonna M: Cutting edge: CD96 (Tactile) promotes NK cell-target cell adhesion by interacting with the poliovirus receptor (CD155). J Immunol (2004) 172(7):3994- 3998.
26. Fuchs A, Colonna M: The role of NK cell recognition of nectin and nectin-like proteins in tumor immunosurveillance. Semin Cancer Biol (2006) 16(5):359-366.
27. Minas K, Liversidge J: Is the CD200/CD200 receptor interaction more than just a myeloid cell inhibitory signal? Crit Rev Immunol (2006) 26(3):213-230.
28. Bottino C, Castriconi R, Moretta L, Moretta A: Cellular ligands of activating NK receptors. Trends Immunol (2005) 26(4):221-226.
29. Bottino C, Castriconi R, Pende D, Rivera P, Nanni M, Carnemolla B, Cantoni C, Grassi J, Marcenaro S, Reymond N, Vitale M et al: Identification of PVR (CD155) and nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule. J Exp Med (2003) 198(4):557-567. •• First delineation of PVR and nectin-2 as DNAM-1 ligands.
30. Tahara-Hanaoka S, Shibuya K, Onoda Y, Zhang H, Yamazaki S, Miyamoto A, Honda S, Lanier LL, Shibuya A: Functional characterization of DNAM-1 (CD226) interaction with its ligands PVR (CD155) and nectin-2 (PRR-2/CD112). Int Immunol (2004) 16(4):533-538.
31. Tahara-Hanaoka S, Shibuya K, Kai H, Miyamoto A, Morikawa Y, Ohkochi N, Honda S, Shibuya A: Tumor rejection by the poliovirus receptor family ligands of the DNAM-1 (CD226) receptor. Blood (2006) 107(4):1491- 1496.
32. Morimoto K, Satoh-Yamaguchi K, Hamaguchi A, Inoue Y, Takeuchi M, Okada M, Ikeda W, Takai Y, Imai T: Interaction of cancer cells with platelets mediated by necl-5/poliovirus receptor enhances cancer cell metastasis to the lungs. Oncogene (2008) 27(3):264-273.
33. Maier MK, Seth S, Czeloth N, Qiu Q, Ravens I, Kremmer E, Ebel M, Müller W, Pabst O, Förster R, Bernhardt G: The adhesion receptor CD155 determines the magnitude of humoral immune responses against orally ingested antigens. Eur J Immunol (2007) 37(8):2214-2225.
34. Castriconi R, Dondero A, Corrias MV, Lanino E, Pende D, Moretta L, Bottino C, Moretta A: Natural killer cell-mediated killing of freshly isolated neuroblastoma cells: Critical role of DNAX accessory molecule-1-poliovirus receptor interaction. Cancer Res (2004) 64(24):9180-9184.
35. El-Sherbiny YM, Meade JL, Holmes TD, McGonagle D, Mackie SL, Morgan AW, Cook G, Feyler S, Richards SJ, Davies FE, Morgan GJ et al: The requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cells. Cancer Res (2007) 67(18):8444-8449.
36. Moretta L, Bottino C, Pende D, Castriconi R, Mingari MC, Moretta A: Surface NK receptors and their ligands on tumor cells. Semin Immunol (2006) 18(3):151-158.
37. Pende D, Bottino C, Castriconi R, Cantoni C, Marcenaro S, Rivera P, Spaggiari GM, Dondero A, Carnemolla B, Reymond N, Mingari MC et al: PVR (CD155) and nectin-2 (CD112) as ligands of the human DNAM-1 (CD226) activating receptor: Involvement in tumor cell lysis. Mol Immunol (2005) 42(4):463-469.
38. Pende D, Spaggiari GM, Marcenaro S, Martini S, Rivera P, Capobianco A, Falco M, Lanino E, Pierri I, Zambello R, Bacigalupo A et al: Analysis of the receptor-ligand interactions in the natural killer-mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: Evidence for the involvement of the poliovirus receptor (CD155) and nectin-2 (CD112). Blood (2005) 105(5):2066-2073.
39. Belisle JA, Gubbels JA, Raphael CA, Migneault M, Rancourt C, Connor JP, Patankar MS: Peritoneal natural killer cells from epithelial ovarian cancer patients show an altered phenotype and bind to the tumour marker MUC16 (CA125). Immunology (2007) 122(3):418-429.
40. Yamamoto F, Yamamoto M: Scanning copy number and gene expression on the 18q21-qter chromosomal region by the systematic multiplex PCR and reverse transcription-PCR methods. Electrophoresis (2007) 28(12):1882-1895.
41. Storojeva I, Boulay JL, Ballabeni P, Buess M, Terracciano L, Laffer U, Mild G, Herrmann R, Rochlitz C: Prognostic and predictive relevance of DNAM-1, SOCS6 and CADH-7 genes on chromosome 18q in colorectal cancer. Oncology (2005) 68(2-3):246-255.
42. Kakehi S, Nakahama K, Morita I: Expression and possible role of PVR/CD155/necl-5 in osteoclastogenesis. Mol Cell Biochem (2007) 301(1-2):209-217.
43. Oda T, Ohka S, Nomoto A: Ligand stimulation of CD155α inhibits cell adhesion and enhances cell migration in fibroblasts. Biochem Biophys Res Commun (2004) 319(4):1253-1264.
44. Reymond N, Imbert AM, Devilard E, Fabre S, Chabannon C, Xerri L, Farnarier C, Cantoni C, Bottino C, Moretta A, Dubreuil P et al: DNAM-1 and PVR regulate monocyte migration through endothelial junctions. J Exp Med (2004) 199(10):1331-1341.
45. Pende D, Castriconi R, Romagnani P, Spaggiari GM, Marcenaro S, Dondero A, Lazzeri E, Lasagni L, Martini S, Rivera P, Capobianco A et al: Expression of the DNAM-1 ligands, nectin-2 (CD112) and poliovirus receptor (CD155), on dendritic cells: Relevance for natural killer-dendritic cell interaction. Blood (2006) 107(5):2030-2036.
46. Edwards RJ, Moran N, Devocelle M, Kiernan A, Meade G, Signac W, Foy M, Park SD, Dunne E, Kenny D, Shields DC: Bioinformatic discovery of novel bioactive peptides. Nat Chem Biol (2007) 3(2):108-112.
47. Bryceson YT, March ME, Ljunggren HG, Long EO: Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion. Blood (2006) 107(1):159-166.
48. Munitz A, Bachelet I, Fraenkel S, Katz G, Mandelboim O, Simon HU, Moretta L, Colonna M, Levi-Schaffer F: 2B4 (CD244) is expressed and functional on human eosinophils. J Immunol (2005) 174(1):110-118.
49. Wang D, Zhang X, Xu X, Song C, Xu Z, Jin B: Generation of rat monoclonal antibodies against murine PTA1/CD226. Hybridoma (2007) 26(2):73-77.
50. Jinquan T, Li W, Yuling H, Lang C: All roads lead to Rome: Pathways of NKT cells promoting asthma. Arch Immunol Ther Exp (2006) 54(5):335-340.
51. Mavilio D, Lombardo G, Kinter A, Fogli M, La Sala A, Ortolano S, Farschi A, Follmann D, Gregg R, Kovacs C, Marcenaro E et al: Characterization of the defective interaction between a subset of natural killer cells and dendritic cells in HIV-1 infection. J Exp Med (2006) 203(10):2339-2350.
52. Tao D, Shangwu L, Qun W, Yan L, Wei J, Junyan L, Feili G, Boquan J, Jinquan T: CD226 expression deficiency causes high sensitivity to apoptosis in NK T cells from patients with systemic lupus erythematosus. J Immunol (2005) 174(3):1281-1290.
53. Shibuya K, Lanier LL, Phillips JH, Ochs HD, Shimizu K, Nakayama E, Nakauchi H, Shibuya A: Physical and functional association of LFA-1 with DNAM-1 adhesion molecule. Immunity (1999) 11(5):615-623.
54. Castriconi R, Dondero A, Cantoni C, Della Chiesa M, Prato C, Nanni M, Fiorini M, Notarangelo L, Parolini S, Moretta L, Notarangelo L et al: Functional characterization of natural killer cells in type I leukocyte adhesion deficiency. Blood (2007) 109(11):4873-4881.
55. Shirakawa J, Wang Y, Tahara-Hanaoka S, Honda S, Shibuya K, Shibuya A: LFA-1-dependent lipid raft recruitment of DNAM-1 (CD226) in CD4+ T cell. Int Immunol (2006) 18(6):951-957.